» Authors » P K Tyagi

P K Tyagi

Explore the profile of P K Tyagi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 143
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tyagi M, Tyagi P, Singh S, Sathpathy S, Kant S, Gupta S, et al.
Med J Armed Forces India . 2023 May; 79(3):300-308. PMID: 37193519
Background: Hospital administrators are often challenged with overcrowding at hospitals. The study hospital receives referred patients; however, they have to wait in long queues even for getting registered. This was...
2.
Tyagi M, Tyagi P, Singh S, Satpathy S, Kant S, Gupta S, et al.
Med J Armed Forces India . 2022 Sep; 78(Suppl 1):S163-S171. PMID: 36147384
Background: Cancellation of surgeries is a regular phenomenon in any hospital, and reasons may vary from clinical to managerial ones. The aim of the study is to suggest scheduling to...
3.
Tilak R, Kunwar R, Tyagi P, Khera A, Joshi R, Wankhade U
Indian J Public Health . 2017 Sep; 61(3):174-181. PMID: 28928300
Background: The global resurgence of rickettsial diseases and their potential to impact the fitness of military personnel and inflict widespread casualties amongst civil populations has emerged as a major cause...
4.
Gupta R, Mishra N, Kumar A, Rana R, Srivastava B, Tyagi P, et al.
Parasitol Res . 2015 Jun; 114(9):3487-96. PMID: 26113507
Antimalarial drug resistance including artemisinin resistance in Plasmodium falciparum malaria is a major concern in combating malaria throughout the world. Delayed parasite clearance time (PCT) is indicative of emergence of...
5.
Valecha N, Krudsood S, Tangpukdee N, Mohanty S, Sharma S, Tyagi P, et al.
Clin Infect Dis . 2012 May; 55(5):663-71. PMID: 22586253
Background: Artemisinin-based combination therapy is the first-line treatment for uncomplicated falciparum malaria. This study assessed the antimalarial efficacy and safety of a combination of 150 mg of arterolane maleate and...
6.
Valecha N, Looareesuwan S, Martensson A, Abdulla S, Krudsood S, Tangpukdee N, et al.
Clin Infect Dis . 2010 Aug; 51(6):684-91. PMID: 20687837
Background: Drug-resistant Plasmodium falciparum malaria necessitates development of novel drugs for treatment.The present study assessed the efficacy and safety of 3 dose levels of arterolane (RBx 11160), a synthetic trioxolane,...
7.
Sharma S, Upadhyay A, Haque M, Tyagi P, Mohanty S, Mittal P, et al.
Indian J Med Res . 2009 Nov; 130(4):458-66. PMID: 19942752
Background & Objectives: Insecticide incorporated plastic sheeting is a new technology to control mosquitoes in emergency shelter places and also temporary habitations in different locations. Therefore, field studies were conducted...
8.
Valecha N, Joshi H, Mallick P, Sharma S, Kumar A, Tyagi P, et al.
Acta Trop . 2009 May; 111(1):21-8. PMID: 19426658
Drug resistance in Plasmodium falciparum poses a major threat to malaria control globally; including India. Chloroquine is still the most widely used drug in the country because of its safety...
9.
Sharma S, Upadhyay A, Haque M, Tyagi P, Mohanty S, Raghavendra K, et al.
J Med Entomol . 2009 Apr; 46(2):342-50. PMID: 19351086
A village-scale trial was conducted on the efficacy of Olyset nets: a long-lasting insecticidal net (LLIN) factory treated with 2% wt:wt permethrin against malaria vectors Anopheles culicifacies Giles and Anopheles...
10.
Biswas S, Seth R, Tyagi P, Sharma S, Dash A
Scand J Immunol . 2007 Dec; 67(2):177-84. PMID: 18086262
This study was aimed to assess the prevalence of naturally acquired humoral immune responses and their association with reduced susceptibility to malaria in children and adults with differential clinical conditions...